Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Mineralys Therapeutics, Inc. | StockGist | StockGist

Companies
MLYS
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings MLYSSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Mineralys Therapeutics, Inc.

Filed Jan 21, 2026

Accepted Jan 20, 2026, 7:00 PM ET

CIK 0001933414

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Mineralys Therapeutics, Inc.

Person Type

HC

CUSIP: 603170101

Recent Filings

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.3 weeks ago

Mineralys Therapeutics, Inc.1 months ago

Mineralys Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice